Search Within

Clemens Hinterleitner

Formats
  1. Journal Article (8)
Groups
  1. Sloan Kettering Institute Postdocs (8)
  2. Adult Leukemia (1)
  3. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  4. Alumni (GSK) (1)
  5. Cancer Biology and Genetics Program Faculty (1)
  6. Center for Hematologic Malignancies (1)

More Groups

People
  1. Courtenay Graham (1)
  2. Ines Fernandez Maestre (1)
  3. Judith Feucht (1)
  4. Lee Jones (1)
  5. Matthew Wereski (1)
  6. Michel Sadelain (1)

More People

Years
  1. 2024 (2)
  2. 2023 (4)
  3. 2022 (2)
Publications
  1. Cancers (1)
  2. Clinical Nuclear Medicine (1)
  3. Experimental and Therapeutic Medicine (1)
  4. Frontiers in Endocrinology (1)
  5. Frontiers in Oncology (1)
  6. Journal of Cancer Research and Clinical Oncology (1)

More Publications

Publishers
  1. Frontiers Media S.A. (2)
  2. MDPI (2)
  3. Lippincott Williams & Wilkins (1)
  4. Nature Publishing Group (1)
  5. Spandidos Publications (1)
  6. Springer (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction
    Journal Article

    Amor, C.; Fernández-Maestre, I.; Chowdhury, S.; Ho, Y. J.; Nadella, S.; Graham, C.; Carrasco, S. E.; Nnuji-John, E.; Feucht, J.; Hinterleitner, C.; more...
    Nature Aging (2024)

    Fulltext@MSK | Save
  • Radiosensitizing favors response to peptide receptor radionuclide therapy in patients with highly proliferative neuroendocrine malignancies: Preliminary evidence from a clinical pilot study
    Journal Article

    Trautwein, N. F.; Hinterleitner, C.; Kiefer, L. S.; Singer, S.; Mattern, S.; Schwenck, J.; Reischl, G.; Sipos, B.; Lauer, U. M.; Dittmann, H.; more...
    Clinical Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Treatment modalities favoring outcome in well-differentiated neuroendocrine tumors G3
    Journal Article

    Hinterleitner, M.; Pfeiffer, R.; Trautwein, N. F.; Sipos, B.; Singer, S.; Nadalin, S.; Königsrainer, A.; Lauer, U. M.; la Fougère, C.; Zender, L.; more...
    Frontiers in Endocrinology (2023)

    Fulltext@MSK | Save
  • Myasthenia gravis as initial presentation of a pancreatic neuroendocrine tumor: A case report
    Journal Article

    Stingu, E.; Dobrowolski, J. M.; Bombach, P.; Nann, D.; Singer, S.; Horger, M.; Lauer, U. M.; Zender, L.; Hinterleitner, C.; Hinterleitner, M.
    Experimental and Therapeutic Medicine (2023)

    Fulltext@MSK | Save
  • Diagnostic approaches for neuroendocrine neoplasms of unknown primary (NEN-UPs) and their prognostic relevance—A retrospective, long-term single-center experience
    Journal Article

    Schmidt, M.; Hinterleitner, C.; Singer, S.; Lauer, U. M.; Zender, L.; Hinterleitner, M.
    Cancers (2023)

    Fulltext@MSK | Save
  • NOTCH3 missense mutations as predictor of long-term response to gemcitabine in a patient with epithelioid hemangioendothelioma
    Journal Article

    Schmidt, M.; Mattern, S.; Singer, S.; Schulze, M.; Biskup, S.; Krumm, P.; Lauer, U. M.; Zender, L.; Hinterleitner, C.; Hinterleitner, M.
    Journal of Cancer Research and Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Inflammatory surrogate parameters for predicting ifosfamide-induced neurotoxicity in sarcoma patients
    Journal Article

    Schmidt, M.; Benzler, K.; Lauer, U. M.; Zender, L.; Hinterleitner, C.; Hinterleitner, M.
    Journal of Clinical Medicine (2022)

    Fulltext@MSK | Save
  • Controversial role of the immune checkpoint OX40L expression on platelets in breast cancer progression
    Journal Article

    Rittig, S. M.; Lutz, M. S.; Clar, K. L.; Zhou, Y.; Kropp, K. N.; Koch, A.; Hartkopf, A. D.; Hinterleitner, M.; Zender, L.; Salih, H. R.; more...
    Frontiers in Oncology (2022)

    Fulltext@MSK | Save